Concert Pharmaceuticals, Inc.

CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing

CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing

April 30, 2008

Broad Syndicate of New and Existing Investors

Selventa

Genstruct and Sirtris Pharmaceuticals Win Bio-IT World’s Best Practices Award

Genstruct and Sirtris Pharmaceuticals Win Bio-IT World’s Best Practices Award

April 30, 2008

Causal Network Modeling Provides Powerful Approach to Modeling Complex Biological Systems for Type 2 Diabetes

Mascoma Corporation

GM and Mascoma Enter into Biofuels Relationship

GM and Mascoma Enter into Biofuels Relationship

May 1, 2008

Automaker to Help Speed One-Step Cellulose-to-Fuels Process to Market

WASHINGTON, May 1 – General Motors Corp. and Mascoma Corp. today announced a strategic relationship to develop cellulosic ethanol focused on Mascoma’s single-step biochemical conversion of non-grain biomass into low-carbon alternative fuels to help address increasing energy demand.

Mascoma Corporation

Mascoma Corporation Raises $61 Million in Third Round of Funding

Mascoma Corporation Raises $61 Million in Third Round of Funding

May 6, 2008

Marathon Oil Corporation Leads Round

VisEn Medical, Inc.

Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials Of Novel Fluorescence Molecular Imaging Technologies

Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials Of Novel Fluorescence Molecular Imaging Technologies

June 16, 2008

Olympus Corporation to Support the Joint Program through the Provision of Novel Imaging Systems

Collaboration Will Bring Innovative Fluorescent Imaging Agent and System Technologies into Clinical Trials in Ovarian Cancer

Affinnova, Inc.

Ideal VP Picks for Presidential Candidates to Be Identified With Evolutionary Optimization Software

Ideal VP Picks for Presidential Candidates to Be Identified With Evolutionary Optimization Software

June 16, 2008

"Secret weapon" technology of major consumer goods companies will search through millions of variations of candidates and issues, rapidly evolving the ideal presidential ticket

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008

Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008

June 24, 2008

Lexington, MA (June 24, 2008) – Concert Pharmaceuticals, Inc. announced today that it has been named to the annual FierceBiotech “Fierce 15” list, designating it as one of the top biotechnology companies of 2008. The editors of FierceBiotech evaluated hundreds of privately-held firms based on a variety of factors including company vision, strength of technology, and competitive market position. A complete list of ‘Fierce 15’ companies is available in today’s issue of FierceBiotech and on the FierceBiotech Web site at www.fiercebiotech.com.

Mascoma Corporation

Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

June 27, 2008

Historic investment set for production facility in U.P.’s Chippewa County

LANSING – Governor Jennifer M. Granholm and Mascoma Corporation CEO Bruce A. Jamerson today announced that the Massachusetts-based company has entered into a series of key strategic relationships to further Mascoma’s efforts to build its first commercial-scale cellulosic ethanol plant in Michigan’s Upper Peninsula.

Affinnova, Inc.

Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

June 30, 2008

Surprise findings include Edwards, Clinton and Giuliani losing ground with likely voters due to polarizing appeal; economy is a top issue, Iraq War is not

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Closes $33 Million Series A Funding

Agios Pharmaceuticals Closes $33 Million Series A Funding

July 7, 2008

Company Founded by Pioneers in Emerging Field of Cancer Metabolism